2009 Study: Occasional cannabis use improves treatment retention in treatment for opiate addiction.

From Society of Cannabis Clinicians
This study published in the American Journal of Addiction in 2009, replicates a previously surprising finding that intermittent cannabis use is associated with improved retention in naltrexone treatment among opioid dependent patients, while both abstinence from cannabis and regular cannabis use during naltrexone treatment are associated with high dropout.


Can Medical Cannabis Stop The ADHD Epidemic?

Kent Mao, Contributor
Waking Times

ADHD seems to be a touchy subject among many doctors, as it remains one of the most controversial yet most common diagnoses in today’s society. It’s interesting to note that, although ADHD is believed to affect 5% of the adult population, it is most often diagnosed in school-age children, leading many to question whether ADHD is an actual disorder or merely a convenient way of dealing with more troublesome kids.  Continue reading



Letter to a Prohibitionist by Barry Lyons

Few books have given me more hope about the end of cannabis prohibition than this insightful treatise. While he does touch on the ‘war on drugs’ in a broader sense, it is his comprehensive review of the last several years of medical studies which make this an invaluable book to have on hand if and when you find yourself defending cannabis in a discussion.

Continue reading

Cheryl Shuman



Stately in stature, immaculately dressed and erudite, the Hollywood socialite sits in a modest Jerusalem coffee bar and speaks with a conviction that only self-help gurus, born-again preachers and Herbalife salesmen seem to be able to muster these days.

She possesses traits found in all of them, this perky, middle-aged cancer survivor who has seen the light and discovered the purpose of her life – she’s the self-described “Martha Stewart of marijuana.” Like a pot evangelist on a mission, the founder of the Beverly Hills Cannabis Club and the Green Asset International Inc. hedge fund dramatically credits cannabis with bringing her back from the brink of death with advanced ovarian cancer, and is intent on spreading the marvels of medical marijuana to the rest of the world.

“In the 1990s, you had the dot.com boom in Silicon Valley. Well, the same thing is about to happen in the cannabis industry around the world – call it the pot.com boom,” laughs Shuman, taking a sip from a cold drink after spending the morning at Hadassah University Medical Center in Jerusalem’s Ein Kerem, home to medical marijuana pioneer Dr. Raphael Mechoulam. Only she’s being dead serious, explaining that according to estimates of US business experts, cannabis will be the foundation of a $47 billion industry by 2016.

Shuman has come to Israel to learn about the highly developed medical marijuana industry in Israel, where over 11,000 patients are licensed to use cannabis to ease symptoms of everything from nausea caused by chemotherapy to the lasting effects of post-traumatic stress disorder. She also hopes to create synergy with Israeli experts in the field and recruit them in her efforts to make quality medical marijuana care available to all patients who need it. It may be a quirk of fate, or according to Shuman something more cosmic, that the organization hosting her stay in Israel is called Tikun Olam.

She and the country’s oldest and largest marijuana-growing dispensary have something in common – they’ve dedicated their energy to repairing the world – one bud of high-grade cannabis at a time.  – FULL ARTICLE